
|Videos|September 13, 2017
- Non-Small Cell Lung Cancer
- Volume 1
- Issue 1
Dr. Langer Discusses the Prevalence of Patients With Non-Driver NSCLC
Corey J. Langer, MD, Perelman Center for Advanced Medicine; Hospital of the University of Pennsylvania, discusses the prevalence of patients with non-driver non-small cell lung cancer (NSCLC).
Advertisement
Articles in this issue
about 8 years ago
Current Treatment Strategies in Nonbiomarker Nonsquamous NSCLCabout 8 years ago
Emerging Treatment Strategies in Nonsquamous NSCLCAdvertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
4
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
5







































